Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PARTNERSHIPS, HEALTH

A Canadian research team conducts first global study of COVID-19 and Celiac disease


TORONTO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- At the advent of the COVID-19 pandemic, a team of researchers from McMaster University?in partnership with the Canadian Celiac Association (CCA)?sought to determine if people with celiac disease were at an increased risk of contracting COVID-19. This is the first large-scale global study of its kind and was led by Dr. Maria Pinto Sanchez at McMaster University.

"Early in the pandemic, every patient in our clinic was asking if their risk of contracting COVID-19 was increased due to their celiac disease. Initially, with the help of student Jamie Zhen, we developed a survey intended to be used just in our clinic, but we saw the potential to bring/take it to a wider audience when my international colleagues expressed interest. After getting the approval of the McMaster ethics board, we brought it to the CCA to help us get the word out to celiacs across Canada," says Dr. Pinto Sanchez.

While the research started in Canada, it quickly expanded to include 18,000 self-reported celiac disease sufferers from across the globe. The survey, which was live from March to June 2020, was conducted with participation from 10 countries (Canada, Argentina, US, Mexico, Argentina, Uruguay, Italy, Spain, New Zealand and Australia) and was also translated into Spanish and Italian. 

"Despite numerous previous studies that have suggested celiac disease is associated with an increased risk of respiratory infections, the research revealed patients with celiac disease were no more at risk of contracting COVID-19 than non-celiacs," says Dr. Pinto Sanchez. "What this means is celiacs need only take the same precautions as the general public: wearing of masks in public, physical distancing of at least 2 metres and adopt a thorough hand-washing protocol."

The results have been published in the journal of Clinical Gastroenterology and Hepatology.

For more details or an interview with the CCA or Dr. Pinto Sanchez, please contact Melissa Secord.

About the Canadian Celiac Association

The Canadian Celiac Association / L'Association canadienne de la maladie coeliaque, a volunteer-based federally registered charitable organization, empowers people who are adversely affected by gluten. It was founded in 1972 and continues to be a source of science-based information, fostering research and encouraging mutual support among the gluten-free community. The association serves people with celiac disease, dermatitis herpetiformis and gluten disorders through its affiliated chapters across Canada.

Media Contact: Melissa Secord, Executive Director

E: [email protected] 

M: 905-507-6208 ext. 226


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: